Andrew E. Budson, M.D. is Chief of Cognitive & Behavioral Neurology, Associate Chief of Staff for Education, and Director of the Center for Translational Cognitive Neuroscience at the Veterans Affairs (VA) Boston Healthcare System, Associate Director and Outreach, Recruitment, and Engagement (ORE) Core Leader at the Boston University Alzheimer’s Disease Research Center, Professor of Neurology at Chobanian and Avedisian School of Medicine, and Lecturer in Neurology at Harvard Medical School. His training included graduating cum laude from Harvard Medical School, being chief resident of the Harvard-Longwood Neurology Residency Program, pursuing a fellowship in dementia at Brigham and Women’s Hospital, and studying memory as a post-doctoral fellow in experimental psychology and cognitive neuroscience at Harvard University. Dr. Budson has had government research funding since 1998, receiving a National Research Service Award and a Career Development Award in addition to a Research Project (R01) grant. He has given over 800 local, national, and international grand rounds and other academic talks. He has published over 150 papers, reviews, and book chapters and is a reviewer for more than 50 journals. He has co-authored or edited eight books, including Memory Loss, Alzheimer’s Disease, and Dementia: A Practical Guide for Clinicians (translated into Spanish, Portuguese, and Japanese), Seven Steps to Managing Your Memory (translated into Korean and Simplified Chinese), Six Steps to Managing Alzheimer’s Disease and Dementia: A Guide for Families, and Why We Forget and How to Remember Better: The Science Behind Memory. He was awarded the Norman Geschwind Prize in Behavioral Neurology in 2008 and the Research Award in Geriatric Neurology in 2009, both from the American Academy of Neurology. His current research uses the techniques of experimental psychology and cognitive neuroscience to understand memory in patients with Alzheimer’s disease. In his memory disorders clinic at the VA Boston Healthcare System he treats patients while teaching fellows, residents, and medical students.
- Associate Director for Research, Alzheimer's Disease Center, Boston University Chobanian & Avedisian School of Medicine
- Professor, Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine
- Consultant Neurologist, Division of Cognitive & Behavioral Neurology, Neurology, Brigham and Women's Hospital
- Associate Chief of Staff for Education, VA Boston Healthcare System
- Director, Center for Translational Cognitive Neuroscience, VA Boston Healthcare System
- Director, Cognitive Neuroscience Research, Alzheimer’s Disease Center, Boston University Chobanian & Avedisian School of Medicine
- Lecturer in Neurology, Neurology, Harvard Medical School
- Physician, Geriatric Research Education Clinical Center & Neurology Services, VA Boston Healthcare System
- VA Boston Healthcare System
- Graduate Faculty (Primary Mentor of Grad Students), Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
- Harvard Medical School, MD
- Harverford College, BA
- Published on 10/21/2022
Morrison MS, Aparicio HJ, Blennow K, Zetterberg H, Ashton NJ, Karikari TK, Tripodis Y, Martin B, Palmisano JN, Sugarman MA, Frank B, Steinberg EG, Turk KW, Budson AE, Au R, Goldstein LE, Jun GR, Kowall NW, Killiany R, Qiu WQ, Stern RA, Mez J, McKee AC, Stein TD, Alosco ML. Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy. Brain. 2022 Oct 21; 145(10):3546-3557. PMID: 35554506.
- Published on 9/1/2022
Price AM, Palumbo R, Marin A, Uppal P, Suh C, Budson AE, Turk KW. Distinguishing Between Genuine and Feigned Dementia Using Event-related Potentials. Cogn Behav Neurol. 2022 Sep 01; 35(3):188-197. PMID: 35830243.
- Published on 6/15/2022
Kim B, Grech SM, Rembisz AE, Pinkerson AI, Topor DR, Ramirez DM, Budson AE, Funk MC. Development and Pilot of a Process for Regularly Sharing Summary Patient Safety Data. Acad Psychiatry. 2022 Jun 15. PMID: 35704161.
- Published on 4/20/2022
Frank B, Ally M, Tripodis Y, Puzo C, Labriolo C, Hurley L, Martin B, Palmisano J, Chan L, Steinberg E, Turk K, Budson A, O'Connor M, Au R, Qiu WQ, Goldstein L, Kukull W, Kowall N, Killiany R, Stern R, Stein T, McKee A, Mez J, Alosco M. Trajectories of Cognitive Decline in Brain Donors With Autopsy-Confirmed Alzheimer Disease and Cerebrovascular Disease. Neurology. 2022 Jun 14; 98(24):e2454-e2464. PMID: 35444054.
- Published on 3/28/2022
Clark EL, Daley RT, Deason RG, O'Connor MK, Budson AE, DeCaro RE. Cue-utilization in the imagination inflation effect paradigm in older adults with mild cognitive impairment. Neuropsychology. 2022 May; 36(4):297-313. PMID: 35343730.
- Published on 2/9/2022
Turk KW, Geada A, Alvarez VE, Xia W, Cherry JD, Nicks R, Meng G, Daley S, Tripodis Y, Huber BR, Budson AE, Dwyer B, Kowall NW, Cantu RC, Goldstein LE, Katz DI, Stern RA, Alosco ML, Mez J, McKee AC, Stein TD. A comparison between tau and amyloid-ß cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease. Alzheimers Res Ther. 2022 02 09; 14(1):28. PMID: 35139894.
- Published on 12/2/2021
Frank B, Ally M, Brekke B, Zetterberg H, Blennow K, Sugarman MA, Ashton NJ, Karikari TK, Tripodis Y, Martin B, Palmisano JN, Steinberg EG, Simkina I, Turk KW, Budson AE, O'Connor MK, Au R, Goldstein LE, Jun GR, Kowall NW, Stein TD, McKee AC, Killiany R, Qiu WQ, Stern RA, Mez J, Alosco ML. Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau. Alzheimers Dement. 2022 Aug; 18(8):1523-1536. PMID: 34854549.
- Published on 8/1/2021
Vives-Rodriguez A, Turk KW, Vassey EA, Singhal T, Cho CH, Budson AE. Reversible Amnestic Cognitive Impairment in a Patient With Brain Sagging Syndrome. Neurol Clin Pract. 2021 Aug; 11(4):e551-e554. PMID: 34484956.
- Published on 7/15/2021
Tao Q, Alvin Ang TF, Akhter-Khan SC, Itchapurapu IS, Killiany R, Zhang X, Budson AE, Turk KW, Goldstein L, Mez J, Alosco ML, Qiu WQ. Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous Apolipoprotein E ?4 Carriers. Neurology. 2021 Jul 15. PMID: 34266923.
- Published on 6/14/2021
Turk KW, Marin A, Schiloski KA, Vives-Rodriguez AL, Uppal P, Suh C, Dwyer B, Palumbo R, Budson AE. Head Injury Exposure in Veterans Presenting to Memory Disorders Clinic: An Observational Study of Clinical Characteristics and Relationship of Event-Related Potentials and Imaging Markers. Front Neurol. 2021; 12:626767. PMID: 34194379.
View 131 more publications: View full profile at BUMC